46 related articles for article (PubMed ID: 32051331)
21. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
[TBL] [Abstract][Full Text] [Related]
22. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
[TBL] [Abstract][Full Text] [Related]
23. Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey.
Kou KO; Poon CF; Tse WC; Mak SL; Leung KY
BMC Pregnancy Childbirth; 2015 Sep; 15():199. PubMed ID: 26330276
[TBL] [Abstract][Full Text] [Related]
24. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
[TBL] [Abstract][Full Text] [Related]
25. Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.
Ngan OMY; Yi H; Ahmed S
BMC Health Serv Res; 2018 Sep; 18(1):731. PubMed ID: 30241520
[TBL] [Abstract][Full Text] [Related]
26. Second tier non-invasive prenatal testing in a regional prenatal diagnosis service unit: a retrospective analysis and literature review.
Ng VKS; Chan AL; Lau WL; Leung WC
Hong Kong Med J; 2020 Feb; 26(1):10-18. PubMed ID: 32051331
[TBL] [Abstract][Full Text] [Related]
27. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
28. [Non-invasive prenatal testing is a breakthrough in prenatal screening].
Hornstrup LS; Ambye L; Sørensen S; Jørgensen FS
Ugeskr Laeger; 2015 Jul; 177(28):. PubMed ID: 26239855
[TBL] [Abstract][Full Text] [Related]
29. An update on current prenatal testing options: first trimester and noninvasive prenatal testing.
Latendresse G; Deneris A
J Midwifery Womens Health; 2015; 60(1):24-36; quiz 111. PubMed ID: 25712277
[TBL] [Abstract][Full Text] [Related]
30. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
Kagan KO; Eiben B; Kozlowski P
Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
[TBL] [Abstract][Full Text] [Related]
31. Issues associated with possible implementation of Non-Invasive Prenatal Testing (NIPT) in first-tier screening: A rapid scoping review.
Ghiasi M; Armour C; Walker M; Shaver N; Bennett A; Little J
Prenat Diagn; 2023 Jan; 43(1):62-71. PubMed ID: 36461628
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
33. Antenatal screening for Down's syndrome.
Wald NJ; Kennard A; Hackshaw A; McGuire A
J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
Benn P; Cuckle H; Pergament E
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
[TBL] [Abstract][Full Text] [Related]
35. Preserving women's reproductive autonomy while promoting the rights of people with disabilities?: the case of Heidi Crowter and Maire Lea-Wilson in the light of NIPT debates in England, France and Germany.
Perrot A; Horn R
J Med Ethics; 2023 Jul; 49(7):471-473. PubMed ID: 35347082
[TBL] [Abstract][Full Text] [Related]
36. Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?
Hill M; Barrett A; Choolani M; Lewis C; Fisher J; Chitty LS
Prenat Diagn; 2017 Dec; 37(13):1281-1290. PubMed ID: 29111614
[TBL] [Abstract][Full Text] [Related]
37. The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review.
Perrot A; Horn R
Eur J Hum Genet; 2022 Jun; 30(6):676-681. PubMed ID: 34602609
[TBL] [Abstract][Full Text] [Related]
38. Health professionals and scientists' views on genome-wide NIPT in the French public health system: Critical analysis of the ethical issues raised by prenatal genomics.
Perrot A; Horn R
PLoS One; 2022; 17(11):e0277010. PubMed ID: 36318580
[TBL] [Abstract][Full Text] [Related]
39. "Overestimated technology - underestimated consequences" - reflections on risks, ethical conflicts, and social disparities in the handling of non-invasive prenatal tests (NIPTs).
Baldus M
Med Health Care Philos; 2023 Jun; 26(2):271-282. PubMed ID: 36932273
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
